Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling

Abstract Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI). Biological correction of the conduction inhomogeneity that underlies re-entry could be a major advance in infarction therapy. As minimal increases in conduction of infar...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wilhelm Roell, Alexandra M. Klein, Martin Breitbach, Torsten S. Becker, Ashish Parikh, Jane Lee, Katrin Zimmermann, Shaun Reining, Beth Gabris, Annika Ottersbach, Robert Doran, Britta Engelbrecht, Miriam Schiffer, Kenichi Kimura, Patricia Freitag, Esther Carls, Caroline Geisen, Georg D. Duerr, Philipp Sasse, Armin Welz, Alexander Pfeifer, Guy Salama, Michael Kotlikoff, Bernd K. Fleischmann
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3cdf27391ef1464998db4351fd85b5c0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3cdf27391ef1464998db4351fd85b5c0
record_format dspace
spelling oai:doaj.org-article:3cdf27391ef1464998db4351fd85b5c02021-12-02T12:32:47ZOverexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling10.1038/s41598-018-25147-82045-2322https://doaj.org/article/3cdf27391ef1464998db4351fd85b5c02018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25147-8https://doaj.org/toc/2045-2322Abstract Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI). Biological correction of the conduction inhomogeneity that underlies re-entry could be a major advance in infarction therapy. As minimal increases in conduction of infarcted tissue markedly influence VT susceptibility, we reasoned that enhanced propagation of the electrical signal between non-excitable cells within a resolving infarct might comprise a simple means to decrease post-infarction arrhythmia risk. We therefore tested lentivirus-mediated delivery of the gap-junction protein Connexin 43 (Cx43) into acute myocardial lesions. Cx43 was expressed in (myo)fibroblasts and CD45+ cells within the scar and provided prominent and long lasting arrhythmia protection in vivo. Optical mapping of Cx43 injected hearts revealed enhanced conduction velocity within the scar, indicating Cx43-mediated electrical coupling between myocytes and (myo)fibroblasts. Thus, Cx43 gene therapy, by direct in vivo transduction of non-cardiomyocytes, comprises a simple and clinically applicable biological therapy that markedly reduces post-infarction VT.Wilhelm RoellAlexandra M. KleinMartin BreitbachTorsten S. BeckerAshish ParikhJane LeeKatrin ZimmermannShaun ReiningBeth GabrisAnnika OttersbachRobert DoranBritta EngelbrechtMiriam SchifferKenichi KimuraPatricia FreitagEsther CarlsCaroline GeisenGeorg D. DuerrPhilipp SasseArmin WelzAlexander PfeiferGuy SalamaMichael KotlikoffBernd K. FleischmannNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Wilhelm Roell
Alexandra M. Klein
Martin Breitbach
Torsten S. Becker
Ashish Parikh
Jane Lee
Katrin Zimmermann
Shaun Reining
Beth Gabris
Annika Ottersbach
Robert Doran
Britta Engelbrecht
Miriam Schiffer
Kenichi Kimura
Patricia Freitag
Esther Carls
Caroline Geisen
Georg D. Duerr
Philipp Sasse
Armin Welz
Alexander Pfeifer
Guy Salama
Michael Kotlikoff
Bernd K. Fleischmann
Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling
description Abstract Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI). Biological correction of the conduction inhomogeneity that underlies re-entry could be a major advance in infarction therapy. As minimal increases in conduction of infarcted tissue markedly influence VT susceptibility, we reasoned that enhanced propagation of the electrical signal between non-excitable cells within a resolving infarct might comprise a simple means to decrease post-infarction arrhythmia risk. We therefore tested lentivirus-mediated delivery of the gap-junction protein Connexin 43 (Cx43) into acute myocardial lesions. Cx43 was expressed in (myo)fibroblasts and CD45+ cells within the scar and provided prominent and long lasting arrhythmia protection in vivo. Optical mapping of Cx43 injected hearts revealed enhanced conduction velocity within the scar, indicating Cx43-mediated electrical coupling between myocytes and (myo)fibroblasts. Thus, Cx43 gene therapy, by direct in vivo transduction of non-cardiomyocytes, comprises a simple and clinically applicable biological therapy that markedly reduces post-infarction VT.
format article
author Wilhelm Roell
Alexandra M. Klein
Martin Breitbach
Torsten S. Becker
Ashish Parikh
Jane Lee
Katrin Zimmermann
Shaun Reining
Beth Gabris
Annika Ottersbach
Robert Doran
Britta Engelbrecht
Miriam Schiffer
Kenichi Kimura
Patricia Freitag
Esther Carls
Caroline Geisen
Georg D. Duerr
Philipp Sasse
Armin Welz
Alexander Pfeifer
Guy Salama
Michael Kotlikoff
Bernd K. Fleischmann
author_facet Wilhelm Roell
Alexandra M. Klein
Martin Breitbach
Torsten S. Becker
Ashish Parikh
Jane Lee
Katrin Zimmermann
Shaun Reining
Beth Gabris
Annika Ottersbach
Robert Doran
Britta Engelbrecht
Miriam Schiffer
Kenichi Kimura
Patricia Freitag
Esther Carls
Caroline Geisen
Georg D. Duerr
Philipp Sasse
Armin Welz
Alexander Pfeifer
Guy Salama
Michael Kotlikoff
Bernd K. Fleischmann
author_sort Wilhelm Roell
title Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling
title_short Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling
title_full Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling
title_fullStr Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling
title_full_unstemmed Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell coupling
title_sort overexpression of cx43 in cells of the myocardial scar: correction of post-infarct arrhythmias through heterotypic cell-cell coupling
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/3cdf27391ef1464998db4351fd85b5c0
work_keys_str_mv AT wilhelmroell overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT alexandramklein overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT martinbreitbach overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT torstensbecker overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT ashishparikh overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT janelee overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT katrinzimmermann overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT shaunreining overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT bethgabris overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT annikaottersbach overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT robertdoran overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT brittaengelbrecht overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT miriamschiffer overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT kenichikimura overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT patriciafreitag overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT esthercarls overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT carolinegeisen overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT georgdduerr overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT philippsasse overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT arminwelz overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT alexanderpfeifer overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT guysalama overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT michaelkotlikoff overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
AT berndkfleischmann overexpressionofcx43incellsofthemyocardialscarcorrectionofpostinfarctarrhythmiasthroughheterotypiccellcellcoupling
_version_ 1718393972440694784